Subscribe To
Diffusion pharmaceuticals (dffn) stock: 1-for-50 reverse stock split announced
Diffusion pharmaceuticals Inc. (NASDAQ: DFFN) announced it will effect a 1-for-50 reverse stock split o...
April 18, 2022, 8:28 pm
Johnson & johnson set to report earnings on tuesday morning
#Johnson&Johnson #Johnson&Johnsonstock # pharmaceutical company Johnson & Johnson is set to release its...
April 18, 2022, 7:22 pm
Why biocryst pharmaceuticals stock sank today
Another analyst gets notably less enthusiastic about the company's prospects....
April 18, 2022, 5:40 pm
Ibb: healthcare dashboard for april
pharmaceuticals and biotechnology still are attractive regarding value and quality. Other subsectors ar...
April 18, 2022, 1:58 pm
Edesa biotech: leader in developing treatments for covid-19 and acd
Edesa is one of 4 pharmaceutical companies that received a grant from the Canadian government to develo...
April 18, 2022, 1:53 pm
Diffusion pharmaceuticals' 50-for-1 stock split will go into effect tomorrow
Diffusion pharmaceuticals Inc (NASDAQ: DFFN) will effect a 1-for-50 reverse stock split of its commo...
April 18, 2022, 10:52 am
Why diffusion pharmaceuticals shares are falling
Diffusion pharmaceuticals Inc (NASDAQ: DFFN) shares are trading lower by 20.83% at $0.21 after the comp...
April 18, 2022, 9:48 am
Tesla earnings follow musk's take-it-or-leave-it twitter bid
First-quarter earnings season starts to heat up this week. Among the notable names on the earnings calendar are electric carmaker Tesla (TSLA, $986.01...
April 18, 2022, 6:33 am
3 reasons vertex pharmaceuticals is a top stock to buy now
A research engine fueled by a $7.6 billion-per-year franchise is cranking out one hit after another....
April 16, 2022, 6:18 am
Alkermes: turning the tides towards profitability
Alkermes is a publicly-traded company that offers biopharmaceutical products and technology. The compan...
April 16, 2022, 1:41 am
Should you invest in the spdr s&p pharmaceuticals etf (xph)?
Sector ETF report for XPH...
April 15, 2022, 7:32 am
Why biochryst pharmaceuticals' stock jumped 14.7% this week
Investors returned to the stock after last week's sell-off....
April 14, 2022, 6:07 pm
Citius pharmaceuticals to present at the noblecon18 investor conference on april 20, 2022
CRANFORD, N.J. , April 14, 2022 /PRNewswire/ -- Citius pharmaceuticals, Inc. ("Citius" or the "Company"...
April 14, 2022, 9:25 am
Biohaven pharmaceutical: recent growth will continue
Biohaven pharmaceutical has a significant portfolio of innovative product candidates across neurologica...
April 14, 2022, 4:23 am
Knight therapeutics - a marshmallow test of patience
Knight Therapeutics Inc. ( TSX:GUD , Financial) is a specialty pharmaceutical company headquartered in ...
April 13, 2022, 3:01 pm
Gilead sciences: the most undervalued pharmaceutical company
According to my DCF analysis, GILD stock has a potential upside of almost 100%. After 7 years of stalemate, Gilead Sciences may be ready to reverse it...
April 13, 2022, 2:55 pm
Late-stage biopharmaceutical sierra oncology announces acquisition by gsk
Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmithKline PLC (LON: GSK) for $55 a share i...
April 13, 2022, 1:49 pm
Antares pharma stock rockets after halozyme buyout deal for a near-50% premium
Shares of Antares Pharma Inc. ATRS, -0.27% rocketed 46.3% in premarket trading Wednesday toward a two-decade high, after the specialty ...
April 13, 2022, 6:12 am
Glaxosmithkline to buy sierra oncology for $1.9 billion
pharmaceutical giant GlaxoSmithKline PLC said Wednesday that it is buying bio...
April 13, 2022, 2:36 am
Gsk to buy sierra oncology for $1.9 billion
Britain's GlaxoSmithKline has agreed to buy California-based biopharmaceutical company Sierra Oncology ...
April 13, 2022, 2:23 am